Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Dizal Pharma logo

Dizal Pharma

Recent Finacing

Equity

Recent Raise

$100M

Dizal Pharmaceutical is a China-based pharmaceutical joint venture owned by SDIC Fund Management, AstraZeneca, and Zytz Partners, operating in drug development, manufacturing, and commercialization.

Founded 2017
Shanghai, China
101-250
Publicly Traded
dizalpharma.com

Highlights

Focus Areas

Biotechnology
Pharmaceutical

Recent Investors

Lilly Asia Ventures logo

Financials

$100M

Total Raised

1

Funding round

1

Investor


Team

Upgrade to view the team

See the team members at Dizal Pharma.